Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / SHS NEW
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1.41M
-
Shares change
-
-18.8K
-
Total reported value, excl. options
-
$7.57M
-
Value change
-
-$131K
-
Put/Call ratio
-
2.5
-
Number of buys
-
6
-
Number of sells
-
-6
-
Price
-
$5.35
Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q1 2024
18 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q1 2024.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.41M shares
.
Largest 10 shareholders include PINNACLE ASSOCIATES LTD (530K shares), VILLERE ST DENIS J & CO LLC (367K shares), Roumell Asset Management, LLC (315K shares), BROWN ADVISORY INC (120K shares), BENJAMIN F. EDWARDS & COMPANY, INC. (50.5K shares), CITADEL ADVISORS LLC (13.2K shares), BANK OF AMERICA CORP /DE/ (7.3K shares), UBS Group AG (4.78K shares), PNC Financial Services Group, Inc. (3.6K shares), and Qube Research & Technologies Ltd (6 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.